Summary
Transfection of genomic DNA from B16 mouse melanoma into LM(TK−) fibroblasts led to the generation of several clones of transfected cells that strongly expressed B 16 melanoma-associated antigens (MAA). The transfected cells retained their H-2k markers and served as allogeneic cells with expressive MAA in C57BL/6 mice, syngeneic with the melanoma. The cells were capable of eliciting primary anti-B16 immune responses in vitro in spleen cells from C57BL/6 mice. Immunization of C57BL/6 mice with the transfected cells led to the generation of anti-B16 cytotoxic activity in spleen cells, and C57BL/6 mice immunized with the MAA-positive transfected cells were partially resistant to a lethal challenge with B16 melanoma cells. Under similar conditions, B16 cells were nonimmunogenic. Therefore, transfected allogeneic LM(TK−) fibroblast cells expressing MAA served as more potent anti-melanoma immunogens than the parental B16 tumor cells themselves.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albino AP, Graf LH Jr, Kantor RR, McLean W, Silagi S, Old LJ (1985) DNA-mediated transfer of human melanoma cells surface glycoprotein gp 130: identification of transfectants by erythrocyte rosetting. Mol Cell Biol 5: 692–697
Andriole GL, Mule JJ, Hansen CT, Linehan WM, Rosenberg SA (1985) Evidence that lymphokine-activated killer cells and natural killer cells are distinct based on an analysis of congenitally immunodeficient mice. J Immunol 135: 2911–2913
Austin P, Trowsdale J, Rudd C, Bodmer W, Feldmann M, Lamb J (1985) Functional expression of HLA-DP genes transfected into mouse fibroblasts. Nature 313: 61–64
Berd B, Maguire HC Jr, Mastrangelo MJ (1986) Induction of cellmediated immunity to autologous melanoma cells and regression of metastases after treatment with melanoma cell vaccine preceded by cyclophosphamide. Cancer Res 46: 2572–2577
Chow HS, Hagen K, Kaizer H, Cohen EP (1987) Formation of macrophage (M) colony-stimulating factor by murine leukemia × fibroblast hybrid cells. J Biol Response Mod 6: 446–456
Chu G, Hayakawa H, Berg P (1987) Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acid Res 15: 1311–1326
Ciliberto G, Dente L, Cortese R (1985) Cell specific expression of a transfected human alpha l-antitrypsin gene. Cell 45: 531–540
Cohen EP, Hagen K (1985) Leukemia × fibroblast hybrid cells augment the antibody response to sheep red blood cells in inbred mice. Immunology 56: 615–623
Collard JG, Van Beek WP, Janssen JW, Schijven JF (1985) Transfection by human oncogenes: concommitant induction of tumorigenicity and tumor-associated membrane alterations. J Cancer 45: 207–213
Deschatrette J, Fougere-Deschatrette C, Corcos L, Schimke RT (1985) Expression of the mouse albumin gene introduced into differentiated and dedifferentiated rat hepatoma cells. Proc Natl Acad Sci USA 82: 765–769
Emi N, Ueda R, Takakhashi T (1985) Isolation of stable mouse L cell transfectant expressing human T cell differentiation antigen Tp40. J Immunol 134: 2817–2819
Fearon ER, Itaya R, Hunt B, Vogelstein B, Frost P (1988) Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene. Cancer Res 48: 2975–2980
Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397–403
Galili N, Naor D, Asjo B, Klein G (1976) Induction of immune responsiveness in a genetically low-responsive tumor host combination by chemical modification of the immunogen. Eur J Immunol 6: 473–476
Graham FL, Van Der Eb AJ (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456–467
Greenberg PD, Klarnet JP, Kern DE, Cheever MA (1988) Therapy of disseminated tumors by adoptive transfer of specifically immune T cells. Prog Exp Tumor Res 32: 104–127
Hammerling GJ, Klar D, Katzav S, Segal S, Feldmann M, Wallich R, Hammerling A (1986) Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes. J Immunogenol 13: 151–157
Hsu C, Kavathas P, Herzenberg LA (1984) Cell-surface antigens expressed on L-cells transfected with whole DNA from nonexpressing and expressing cells. Nature 312: 68–69
Kasid A, Lippman ME, Papageorge AG, Lowy DR, Gelmann EP (1985) Transfection of v-hras DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity. Science 228: 725–728
Kavathas P, Herzenberg LA (1983) Stable transformation of mouse L cells for human membrane T-cell differentiation antigens, HLA and beta 2-microglobulin: selection by fluorescence-activated cell sorting. Proc Natl Acad Sci USA 80: 524–528
Kim BS, Liang W, Cohen EP (1979) Tumor-specific immunity induced by somatic hybrids: I. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids. J Immunol 123: 733–738
Kobayashi H, Sendo F, Kaji H, Shirai T, Saito H, Takeichi N, Hosodawa M, Kodama T (1970) Inhibition of transplanted rat tumors by immunization with identical tumor cells infected with Friend virus. J Natl Cancer Inst 44: 11–19
Krontiris TG, Cooper GM (1981) Transforming activity of human tumor DNAs. Proc Natl Acad Sci USA 78: 1181–1184
Liang W, Cohen EP (1976) Resistance to murine leukemia in mice rejecting syngeneic somatic hybrid cells. J Immunol 116: 623–626
Look AT, Peiper SC, Rebentisch MB, Ashmun RA, Roussel MF, Rettenmier CW, Sher CJ (1985) Transfer and expression of the gene encoding a human myeloid membrane antigen (gp 150). J Clin Invest 75: 569–579
Maitland N, McDougall JK (1977) Biochemical transformation of mouse cells by fragments of HSV DNA. Cell 11: 323–328
Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau H, Lind S (1988) Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res 48: 5883–5893
Overhauser J, Fan H (1985) Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat. J Virol 53: 133–144
Papa MZ, Mule JJ, Rosenberg SA (1986) Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three distinct histological types. Cancer Res 46: 4973–4978
Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318–1321
Shih C, Padhy LC, Murray M, Weinberg RA (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261–264
Slomski R, Hagen K, Kim YS, Cohen EP (1987). Immunity to murine leukemia induced in susceptible mice by transfected mouse fibroblasts. Leukemia 1: 213–219
Toffaletti DL, Darrow TL, Scott DW (1983) Augmentation of syngeneic tumor-specific immunity by semi-allogeneic cell hybrids. J Immunol 130: 2982–2986
Topalian SL, Solomon D, Rosenberg SA (1989) Tumor specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 142: 3714–3725
Wigler M, Pellicer A, Silverstein S, Axel R (1978) Biochemical transfer of single-copy eukaryotic genes using total cellular DNA as donor. Cell 14: 725–731
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, Y.S., Slomski, R. & Cohen, E.P. Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens. Cancer Immunol Immunother 34, 163–168 (1991). https://doi.org/10.1007/BF01742307
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01742307